| Literature DB >> 33474672 |
Fanchon Bourasset1,2, Sylvain Auvity1,2, Robert G Thorne3,4, Jean-Michel Scherrmann5,6.
Abstract
Neuropharmacokinetics considers cerebral drug distribution as a critical process for central nervous system drug action as well as for drug penetration through the CNS barriers. Brain distribution of small molecules obeys classical rules of drug partition, permeability, binding to fluid proteins or tissue components, and tissue perfusion. The biodistribution of all drugs, including both small molecules and biologics, may also be influenced by specific brain properties related to brain anatomy and physiological barriers, fluid dynamics, and cellular and biochemical composition, each of which can exhibit significant interspecies differences. All of these properties contribute to select optimal dosing paradigms and routes of drug delivery to reach brain targets for classical small molecule drugs as well as for biologics. The importance of these properties for brain delivery and exposure also highlights the need for efficient new analytical technologies to more comprehensively investigate drug distribution in the CNS, a complex multi-compartmentalized organ system.Entities:
Keywords: Brain barriers; Cerebral fluids; Delivery routes; Distribution; Extracellular fluid; Heterogeneity
Mesh:
Substances:
Year: 2022 PMID: 33474672 DOI: 10.1007/164_2020_402
Source DB: PubMed Journal: Handb Exp Pharmacol ISSN: 0171-2004